Could a Treaty Address a Broken Pharmaceutical R&D System?
Innovation and Access to Medicines for Neglected Populations
PLoS Medicine "Medical innovation and access to the fruits of scientific progress are no longer policy concerns restricted to the national level or to wealthy countries alone. In an era of health interdependence, effective tools for global governance are required to generate medical R&D as a global public good that can deliver benefits for all. A treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global R&D system. It should be based on the understanding that a politically and financially sustainable system for generating health research will require both fair contributions from all, and fair benefit-sharing for all," conclude Suerie Moon1, Jorge Bermudez and Ellen 't Hoen in an Essay for PLoS Medicine.